2022-09-012023-08-312023-08-31false13571317VITABEL NUTRITION LTD2024-08-28iso4217:GBPxbrli:pure135713172022-09-01135713172023-08-31135713172022-09-012023-08-31135713172021-08-17135713172022-08-31135713172021-08-172022-08-3113571317bus:SmallEntities2022-09-012023-08-3113571317bus:AuditExempt-NoAccountantsReport2022-09-012023-08-3113571317bus:FullAccounts2022-09-012023-08-3113571317bus:PrivateLimitedCompanyLtd2022-09-012023-08-3113571317core:WithinOneYear2023-08-3113571317core:AfterOneYear2023-08-3113571317core:WithinOneYear2022-08-3113571317core:AfterOneYear2022-08-3113571317core:ShareCapital2023-08-3113571317core:SharePremium2023-08-3113571317core:RevaluationReserve2023-08-3113571317core:OtherReservesSubtotal2023-08-3113571317core:RetainedEarningsAccumulatedLosses2023-08-3113571317core:ShareCapital2022-08-3113571317core:SharePremium2022-08-3113571317core:RevaluationReserve2022-08-3113571317core:OtherReservesSubtotal2022-08-3113571317core:RetainedEarningsAccumulatedLosses2022-08-3113571317core:LandBuildings2023-08-3113571317core:PlantMachinery2023-08-3113571317core:Vehicles2023-08-3113571317core:FurnitureFittings2023-08-3113571317core:OfficeEquipment2023-08-3113571317core:NetGoodwill2023-08-3113571317core:IntangibleAssetsOtherThanGoodwill2023-08-3113571317core:ListedExchangeTraded2023-08-3113571317core:UnlistedNon-exchangeTraded2023-08-3113571317core:LandBuildings2022-08-3113571317core:PlantMachinery2022-08-3113571317core:Vehicles2022-08-3113571317core:FurnitureFittings2022-08-3113571317core:OfficeEquipment2022-08-3113571317core:NetGoodwill2022-08-3113571317core:IntangibleAssetsOtherThanGoodwill2022-08-3113571317core:ListedExchangeTraded2022-08-3113571317core:UnlistedNon-exchangeTraded2022-08-3113571317core:LandBuildings2022-09-012023-08-3113571317core:PlantMachinery2022-09-012023-08-3113571317core:Vehicles2022-09-012023-08-3113571317core:FurnitureFittings2022-09-012023-08-3113571317core:OfficeEquipment2022-09-012023-08-3113571317core:NetGoodwill2022-09-012023-08-3113571317core:IntangibleAssetsOtherThanGoodwill2022-09-012023-08-3113571317core:ListedExchangeTraded2022-09-012023-08-3113571317core:UnlistedNon-exchangeTraded2022-09-012023-08-3113571317core:MoreThanFiveYears2022-09-012023-08-3113571317core:Non-currentFinancialInstruments2023-08-3113571317core:Non-currentFinancialInstruments2022-08-3113571317dpl:CostSales2022-09-012023-08-3113571317dpl:DistributionCosts2022-09-012023-08-3113571317core:LandBuildings2022-09-012023-08-3113571317core:PlantMachinery2022-09-012023-08-3113571317core:Vehicles2022-09-012023-08-3113571317core:FurnitureFittings2022-09-012023-08-3113571317core:OfficeEquipment2022-09-012023-08-3113571317dpl:AdministrativeExpenses2022-09-012023-08-3113571317core:NetGoodwill2022-09-012023-08-3113571317core:IntangibleAssetsOtherThanGoodwill2022-09-012023-08-3113571317dpl:GroupUndertakings2022-09-012023-08-3113571317dpl:ParticipatingInterests2022-09-012023-08-3113571317dpl:GroupUndertakingscore:ListedExchangeTraded2022-09-012023-08-3113571317core:ListedExchangeTraded2022-09-012023-08-3113571317dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-09-012023-08-3113571317core:UnlistedNon-exchangeTraded2022-09-012023-08-3113571317dpl:CostSales2021-08-172022-08-3113571317dpl:DistributionCosts2021-08-172022-08-3113571317core:LandBuildings2021-08-172022-08-3113571317core:PlantMachinery2021-08-172022-08-3113571317core:Vehicles2021-08-172022-08-3113571317core:FurnitureFittings2021-08-172022-08-3113571317core:OfficeEquipment2021-08-172022-08-3113571317dpl:AdministrativeExpenses2021-08-172022-08-3113571317core:NetGoodwill2021-08-172022-08-3113571317core:IntangibleAssetsOtherThanGoodwill2021-08-172022-08-3113571317dpl:GroupUndertakings2021-08-172022-08-3113571317dpl:ParticipatingInterests2021-08-172022-08-3113571317dpl:GroupUndertakingscore:ListedExchangeTraded2021-08-172022-08-3113571317core:ListedExchangeTraded2021-08-172022-08-3113571317dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-08-172022-08-3113571317core:UnlistedNon-exchangeTraded2021-08-172022-08-3113571317core:NetGoodwill2023-08-3113571317core:IntangibleAssetsOtherThanGoodwill2023-08-3113571317core:LandBuildings2023-08-3113571317core:PlantMachinery2023-08-3113571317core:Vehicles2023-08-3113571317core:FurnitureFittings2023-08-3113571317core:OfficeEquipment2023-08-3113571317core:AfterOneYear2023-08-3113571317core:WithinOneYear2023-08-3113571317core:ListedExchangeTraded2023-08-3113571317core:UnlistedNon-exchangeTraded2023-08-3113571317core:ShareCapital2023-08-3113571317core:SharePremium2023-08-3113571317core:RevaluationReserve2023-08-3113571317core:OtherReservesSubtotal2023-08-3113571317core:RetainedEarningsAccumulatedLosses2023-08-3113571317core:NetGoodwill2022-08-3113571317core:IntangibleAssetsOtherThanGoodwill2022-08-3113571317core:LandBuildings2022-08-3113571317core:PlantMachinery2022-08-3113571317core:Vehicles2022-08-3113571317core:FurnitureFittings2022-08-3113571317core:OfficeEquipment2022-08-3113571317core:AfterOneYear2022-08-3113571317core:WithinOneYear2022-08-3113571317core:ListedExchangeTraded2022-08-3113571317core:UnlistedNon-exchangeTraded2022-08-3113571317core:ShareCapital2022-08-3113571317core:SharePremium2022-08-3113571317core:RevaluationReserve2022-08-3113571317core:OtherReservesSubtotal2022-08-3113571317core:RetainedEarningsAccumulatedLosses2022-08-3113571317core:NetGoodwill2021-08-1713571317core:IntangibleAssetsOtherThanGoodwill2021-08-1713571317core:LandBuildings2021-08-1713571317core:PlantMachinery2021-08-1713571317core:Vehicles2021-08-1713571317core:FurnitureFittings2021-08-1713571317core:OfficeEquipment2021-08-1713571317core:AfterOneYear2021-08-1713571317core:WithinOneYear2021-08-1713571317core:ListedExchangeTraded2021-08-1713571317core:UnlistedNon-exchangeTraded2021-08-1713571317core:ShareCapital2021-08-1713571317core:SharePremium2021-08-1713571317core:RevaluationReserve2021-08-1713571317core:OtherReservesSubtotal2021-08-1713571317core:RetainedEarningsAccumulatedLosses2021-08-1713571317core:AfterOneYear2022-09-012023-08-3113571317core:WithinOneYear2022-09-012023-08-3113571317core:Non-currentFinancialInstrumentscore:CostValuation2022-09-012023-08-3113571317core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-09-012023-08-3113571317core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-09-012023-08-3113571317core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-09-012023-08-3113571317core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-09-012023-08-3113571317core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-09-012023-08-3113571317core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-09-012023-08-3113571317core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-09-012023-08-3113571317core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-09-012023-08-3113571317core:Non-currentFinancialInstrumentscore:CostValuation2023-08-3113571317core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-3113571317core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-3113571317core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-3113571317core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-3113571317core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-3113571317core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-3113571317core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-3113571317core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-3113571317core:Non-currentFinancialInstrumentscore:CostValuation2022-08-3113571317core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-08-3113571317core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-08-3113571317core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-08-3113571317core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-08-3113571317core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-08-3113571317core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-08-3113571317core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-08-3113571317core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-08-3113571317bus:Director12022-09-012023-08-31

VITABEL NUTRITION LTD

Registered Number
13571317
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2023

VITABEL NUTRITION LTD
Company Information
for the year from 1 September 2022 to 31 August 2023

Director

Anabel Steiner

Company Secretary

Anabel Steiner

Registered Address

27 Old Gloucester Street
London
WC1N 3AX

Registered Number

13571317 (England and Wales)
VITABEL NUTRITION LTD
Balance Sheet as at
31 August 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets31,601-
Investments422,109-
23,710-
Current assets
Debtors550,819450
Cash at bank and on hand2,79978,180
53,61878,630
Creditors amounts falling due within one year6(16,126)(1,892)
Net current assets (liabilities)37,49276,738
Total assets less current liabilities61,20276,738
Net assets61,20276,738
Capital and reserves
Called up share capital143143
Share premium99,95799,957
Profit and loss account(38,898)(23,362)
Shareholders' funds61,20276,738
The financial statements were approved and authorised for issue by the Director on 28 August 2024, and are signed on its behalf by:
Anabel Steiner
Director
Registered Company No. 13571317
VITABEL NUTRITION LTD
Notes to the Financial Statements
for the year ended 31 August 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered office address is 27 Old Gloucester Street, London, WC1N 3AX.
Basis of preparation
The financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland", including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The Financial statements have been prepared under the historical cost convention. The accounting policies set out below have, unless otherwise stated, been applied consistently to the period presented in the financial statements.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on the straight-line basis at the following rate to write off each asset over its estimated useful life. Computer Equipment - 33%
Investments
Investments in subsidiaries' shares which have been classified as fixed asset investments as the company intends to hold them on a continuing basis, are initially measured at cost less any accumulated impairment. They are subsequently remeasured to market value at each balance sheet date. Gains and losses on re-measurement are recognised in profit or loss for the period.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand and call deposits.
Financial instruments
All of the financial instruments of the company are basic and the company has elected to apply the provisions of Section 11 "Basic Financial Instruments of FRS 10” to all its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instruments. Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses. Equity instruments Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company
2.Average number of employees
There were no staff costs for the year ended 31 August 2023 nor for the period ended 31 August 2022.

20232022
Average number of employees during the year00
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
Additions1,7991,799
At 31 August 231,7991,799
Depreciation and impairment
Charge for year198198
At 31 August 23198198
Net book value
At 31 August 231,6011,601
At 31 August 22--
4.Fixed asset investments

Investments in groups1

Total

££
Cost or valuation
Additions22,10922,109
At 31 August 2322,10922,109
Net book value
At 31 August 2322,10922,109
At 31 August 22--

Notes

1Investments in group undertakings and participating interests
5.Debtors: amounts due within one year

2023

2022

££
Other debtors50,819450
Total50,819450
6.Creditors: amounts due within one year

2023

2022

££
Trade creditors / trade payables546-
Taxation and social security12,452-
Other creditors3,1281,892
Total16,1261,892
7.Change in reporting period and impact on comparability
The financial statements for the previous year were prepared for the period from 17 August 2021 to 31 August 2022, while the current year's accounts covered a period of 12 months ending 31 August 2023, and therefore the comparative figures are not comparable.